Category: Hematology & Oncology
United States Hematology & Oncology
-
2024 North America Hematology and Flow Cytometry Database: US, Canada, Mexico - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts
... and sales forecasts for major hematology and flow cytometry tests, including: Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone ... Read More
-
2023 Global Hematology Market Shares in the US, Europe, and Japan - Competitive Analysis of Leading and Emerging Market Players
... US. The report analyses current and emerging suppliers of hematology analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in ... Read More
-
North America Cancer Diagnostics Market, By Products (Instruments, Consumables Services), By Test Type (Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Immunohistochemistry, In Situ Hybridization and Others (Endoscopy, Genetic Tests)), By Application (Breast Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United ... Read More
-
North America In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The North America in-vitro diagnostics market is expected to ... Read More
-
Oncologists Global Market Opportunities And Strategies To 2032 Including: 1) By Cancer Diagnosis And Treatment: Cancer Diagnosis; Cancer Treatment 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer 3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia Covering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, Inc.
... Cancer3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; AcademiaCovering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, ... Read More
-
United States In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others] By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F United States in vitro ... Read More
-
2023-2028 US Hematology and Flow Cytometry Analyzers and Reagents Market - 2023 Supplier Shares, 2023-2028 Test Volume and Sales Segment Forecasts for over 40 Individual Tests for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, P
... Labs, POC Locations, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . LeadingMarketResearch.com ... Read More
-
2023-2027 U.S. Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 North America Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - US, Canada, Mexico - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 3-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in tne USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines ... Read More
-
2023 North America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in the USA, Canada, Mexico - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, ... Read More
-
2023 North America Hematology and Flow Cytometry Analyzers and Reagents Market in the US, Canada and Mexico - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . This new 3-country ... Read More
-
2023 US Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Labs, POC Locations, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . LeadingMarketResearch.com ... Read More
-
2023 Global Hematology and Flow Cytometry Analyzers and Reagents Market in the US, Europe, Japan - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . This comprehensive seven-country report is ... Read More
-
U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2030. Market Segmentation U.S. Pancreatic Cancer Diagnostics Market, By Test ... Read More
-
2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More
-
2023 North America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Canada, Mexico - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into ... Read More
-
United States Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings (Instruments, Reagents & Consumables, and Services), and Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer)
... Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings ... Read More
-
NA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent ... Read More
-
NA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User ... Read More
-
NA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry ... Read More
-
NA Kidney Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type (Renal Cell Carcinoma, Clear cell renal cell carcinoma, non-clear cell renal cell carcinoma), Product (Platform-Based Products, Instrument based products, Kits and Reagents, and Other Consumables), Technology ... Read More
-
U.S. Women Health Laboratory Testing Market - A Region-Wise Analysis: Focus on U.S. Women Health Laboratory Testing Market - Analysis and Forecast, 2022-2030
... laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030. The market is driven by factors ... Read More
-
Femtech Market Size By Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Femtech Market is ... Read More
-
NA Hereditary Cancer Testing Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029. Market Segmentation North America Hereditary Cancer Testing Market, By Test ... Read More
Research Assistance
